2-Bromo-5-chloro-8-methyl-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridine

Catalog No. :
ACEJUP256
CAS No. :
805319-85-1
Molecular Formula :
C8H4BrClN4S
Molecular Weight :
303.57

IUPAC Name:2-bromo-5-chloro-8-methyl-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridine

2-Bromo-5-chloro-8-methyl-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%$542.00Login to see priceInquiryInquiry
50mg97%$920.00Login to see priceInquiryInquiry
100mg97%$1564.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-5-chloro-8-methyl-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridine
IUPAC Name2-bromo-5-chloro-8-methyl-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridine
MDL No.MFCD11878008
Molecular FormulaC8H4BrClN4S
Molecular Weight303.57
SMILESCN1C=NC2=C(Cl)N=C(SC(Br)=N3)C3=C21
InChI KeyHVMRQRTYMJLWFI-UHFFFAOYSA-N
Synonym2-BROMO-5-CHLORO-8-METHYL-8H-IMIDAZO[4,5-D]THIAZOLO[5,4-B]PYRIDINE;7-chloro-4-methyl-2-bromo-4H-imidazo[4,5-d]thiazolo[5,4-b]-pyridine;8H-Imidazo[4,5-d]thiazolo[5,4-b]pyridine, 2-bromo-5-chloro-8-methyl-
CAS No.805319-85-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACEJUP256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEJUP256 route product structure diagram
    ACEJUP256805319-85-1
Inquiry

2. ACEJUP256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEJUP256 route product structure diagram
    ACEJUP256805319-85-1
Inquiry

Comments (0)